2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Advancing human induced pluripotent stem cell‐derived blood‐brain barrier models for studying immune cell interactions

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Human induced pluripotent stem cell (hiPSC)‐derived blood‐brain barrier (BBB) models established to date lack expression of key adhesion molecules involved in immune cell migration across the BBB in vivo. Here, we introduce the extended endothelial cell culture method (EECM), which differentiates hiPSC‐derived endothelial progenitor cells to brain microvascular endothelial cell (BMEC)‐like cells with good barrier properties and mature tight junctions. Importantly, EECM‐BMEC‐like cells exhibited constitutive cell surface expression of ICAM‐1, ICAM‐2, and E‐selectin. Pro‐inflammatory cytokine stimulation increased the cell surface expression of ICAM‐1 and induced cell surface expression of P‐selectin and VCAM‐1. Co‐culture of EECM‐BMEC‐like cells with hiPSC‐derived smooth muscle‐like cells or their conditioned medium further increased the induction of VCAM‐1. Functional expression of endothelial ICAM‐1 and VCAM‐1 was confirmed by T‐cell interaction with EECM‐BMEC‐like cells. Taken together, we introduce the first hiPSC‐derived BBB model that displays an adhesion molecule phenotype that is suitable for the study of immune cell interactions.

          Related collections

          Most cited references73

          • Record: found
          • Abstract: found
          • Article: not found

          Blood-Brain Barrier: From Physiology to Disease and Back

          The blood-brain barrier (BBB) prevents neurotoxic plasma components, blood cells, and pathogens from entering the brain. At the same time, the BBB regulates transport of molecules into and out of the central nervous system (CNS), which maintains tightly controlled chemical composition of the neuronal milieu that is required for proper neuronal functioning. In this review, we first examine molecular and cellular mechanisms underlying the establishment of the BBB. Then, we focus on BBB transport physiology, endothelial and pericyte transporters, and perivascular and paravascular transport. Next, we discuss rare human monogenic neurological disorders with the primary genetic defect in BBB-associated cells demonstrating the link between BBB breakdown and neurodegeneration. Then, we review the effects of genes underlying inheritance and/or increased susceptibility for Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease, and amyotrophic lateral sclerosis (ALS) on BBB in relation to other pathologies and neurological deficits. We next examine how BBB dysfunction relates to neurological deficits and other pathologies in the majority of sporadic AD, PD, and ALS cases, multiple sclerosis, other neurodegenerative disorders, and acute CNS disorders such as stroke, traumatic brain injury, spinal cord injury, and epilepsy. Lastly, we discuss BBB-based therapeutic opportunities. We conclude with lessons learned and future directions, with emphasis on technological advances to investigate the BBB functions in the living human brain, and at the molecular and cellular level, and address key unanswered questions.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The movers and shapers in immune privilege of the CNS

            Engelhardt and colleagues review barriers separating blood from CSF and CNS parenchyma, how pathways draining solutes from CNS to lymph nodes exclude trafficking of antigen-presenting cells and how intravital microscopy has influenced debate on immune privilege of the CNS.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions.

              The tissues of the central nervous system are effectively shielded from the blood circulation by specialized vessels that are impermeable not only to cells, but also to most macromolecules circulating in the blood. Despite this seemingly absolute seclusion, central nervous system tissues are subject to immune surveillance and are vulnerable to autoimmune attacks. Using intravital two-photon imaging in a Lewis rat model of experimental autoimmune encephalomyelitis, here we present in real-time the interactive processes between effector T cells and cerebral structures from their first arrival to manifest autoimmune disease. We observed that incoming effector T cells successively scanned three planes. The T cells got arrested to leptomeningeal vessels and immediately monitored the luminal surface, crawling preferentially against the blood flow. After diapedesis, the cells continued their scan on the abluminal vascular surface and the underlying leptomeningeal (pial) membrane. There, the T cells encountered phagocytes that effectively present antigens, foreign as well as myelin proteins. These contacts stimulated the effector T cells to produce pro-inflammatory mediators, and provided a trigger to tissue invasion and the formation of inflammatory infiltrations.
                Bookmark

                Author and article information

                Contributors
                eshusta@wisc.edu
                bengel@tki.unibe.ch , eshusta@wisc.edu
                Journal
                FASEB J
                FASEB J
                10.1096/(ISSN)1530-6860
                FSB2
                The FASEB Journal
                John Wiley and Sons Inc. (Hoboken )
                0892-6638
                1530-6860
                30 October 2020
                December 2020
                : 34
                : 12 ( doiID: 10.1096/fsb2.v34.12 )
                : 16693-16715
                Affiliations
                [ 1 ] Theodor Kocher Institute University of Bern Bern Switzerland
                [ 2 ] Department of Chemical and Biological Engineering University of Wisconsin Madison WI USA
                [ 3 ] Laboratory of Neuroimmunology Neuroscience Research Centre Lausanne University Hospital and University of Lausanne Lausanne Switzerland
                [ 4 ] Department of Neurology and Clinical Neuroscience Yamaguchi University Graduate School of Medicine Ube Japan
                [ 5 ] Blood Brain Barrier Laboratory University of Artois Lens France
                [ 6 ] Department of Neurological Surgery University of Wisconsin Madison WI USA
                Author notes
                [*] [* ] Correspondence

                Britta Engelhardt, Theodor Kocher Institute, University of Bern, Freiestrasse 1, 3012 Bern, Switzerland.

                Email: bengel@ 123456tki.unibe.ch

                Eric V. Shusta, Department of Chemical and Biological Engineering, Department of Neurological Surgery, University of Wisconsin‐Madison, 1415 Engineering Drive, Madison, WI 53706, USA.

                Email: eshusta@ 123456wisc.edu

                Article
                FSB221149
                10.1096/fj.202001507RR
                7686106
                33124083
                eb0b0fee-4eb1-4a55-800f-82309d180a92
                © 2020 The Authors. The FASEB Journal published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 17 June 2020
                : 10 October 2020
                : 14 October 2020
                Page count
                Figures: 6, Tables: 0, Pages: 23, Words: 32556
                Funding
                Funded by: Bangerter‐Rhyner Foundation
                Funded by: Bern Center for Precision Medicine
                Funded by: Schweizerische Multiple Sklerose Gesellschaft (Swiss Multiple Sclerosis Society) , open-funder-registry 10.13039/501100008486;
                Funded by: ECTRIMS , open-funder-registry 10.13039/100008659;
                Funded by: Uehara Memorial Foundation , open-funder-registry 10.13039/100008732;
                Funded by: JSPS
                Funded by: HHS | NIH | Office of Extramural Research, National Institutes of Health (OER) , open-funder-registry 10.13039/100006955;
                Award ID: NS103844
                Funded by: Swiss National Science Foundation
                Award ID: 320030‐179531
                Funded by: National Science Foundation Graduate Research Fellowship
                Award ID: 1747503
                Funded by: National Institutes of Health Biotechnology Training Program
                Award ID: T32 GM008349
                Categories
                Research Article
                Research Articles
                Custom metadata
                2.0
                December 2020
                Converter:WILEY_ML3GV2_TO_JATSPMC version:5.9.6 mode:remove_FC converted:23.12.2020

                Molecular biology
                blood‐brain barrier,human induced pluripotent stem cells,t‐cell migration,adhesion molecules,vcam‐1

                Comments

                Comment on this article